WHY YOU CAN’T TREAT BREAST CANCER AS ONE DISEASE
Posted by Megan Fellman-Northwestern on
Scientists have identified an overactive protein that may provide a target to treat basal-like breast cancer, a deadly carcinoma that is resistant to many types of chemotherapy.
Basal-like cancer is a category that includes a number of different breast cancers, including the highly aggressive form called triple negative cancer.
No hay comentarios:
Publicar un comentario